BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Drug Development

  Sangamo Presents Hemophilia A Program Data At The 2016 American Society of Hematology Meeting

  December 6, 2016

   · 

  4 min read
• Biotech Bay

  CohBar Continues Exploration Of Mitochondrial Genome And Expansion Of Its IP Portfolio With Filing Of 29 New Provisional Patents

  December 6, 2016

   · 

  5 min read
• Endo International Begins Shipment Of Generic CellCept

  December 6, 2016

   · 

  2 min read
• Drug Development

  Merck & Co. Release: Updated KEYTRUDA (Pembrolizumab) Data In Small Cell Lung Cancer And Mesothelioma Presented At 17th World Conference On Lung Cancer

  December 6, 2016

   · 

  17 min read
• Drug Development

  Janssen R&D Release: Late-breaking Phase 2 Ibrutinib Study In Chronic Graft-Versus-Host-Disease (cGVHD) Showed Complete Or Partial Response In Up To Two-Thirds Of Steroid Dependent Or Refractory Patients

  December 6, 2016

   · 

  11 min read
• Drug Development

  AbbVie Release: Late-Breaking Ibrutinib (IMBRUVICA) Data Show Complete Or Partial Response In Two-Thirds Of Patients With Chronic Graft-Versus-Host-Disease, A Frequent And Potentially Life-Threatening Complication Of Stem Cell Transplant

  December 6, 2016

   · 

  12 min read
• Drug Development

  CTI BioPharma Release: PERSIST-2 Phase 3 Study Of Pacritinib Versus Best Available Therapy Shows Encouraging Clinical Activity In High-Risk Patients With Advanced Myelofibrosis In Late-Breaking Session At American Society of Hematology Annual Meeting

  December 6, 2016

   · 

  13 min read
• FDA

  Medtronic’s Endurant(TM) II/IIs Stent Graft System Receives CE Mark For Use With Chevar Parallel Graft Technique

  December 6, 2016

   · 

  3 min read
• Business

  Asceneuron Appoints J. Michael Ryan, M.D. As Chief Medical Officer

  December 6, 2016

   · 

  2 min read
• Hutchison China MediTech (Chi-Med) Presents Pre-Clinical Data For Selective Syk Inhibitor HMPL-523 At The 2016 American Society of Hematology Annual Meeting

  December 6, 2016

   · 

  5 min read